Status:
COMPLETED
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
Lead Sponsor:
Arizona State University
Collaborating Sponsors:
HonorHealth Research Institute
Conditions:
Hematopoietic Stem Cell Transplantation
Bone Marrow Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients undergoing hematopoietic stem cell transplantation (HCT) often continue to experience anxiety, depression, isolation, and other psychosocial distress due to the severe nature of the transplan...
Detailed Description
This randomized controlled trial will explore the effects of an HRV biofeedback (HRVB) training session with a modified waitlist control in a population of Hematopoietic cell transplantation (HCT) pat...
Eligibility Criteria
Inclusion
- Patient
- age 18 or older
- recently underwent Hematopoietic cell transplantation (HCT) (within 3 months after hospital discharge)
- must be able to speak, read, and write in English
- access to a working phone and e-mail account
- have a smart phone
- Patient
Exclusion
- cognitive impairment that prohibits completion of study assessment visual or hearing impairment
- other (e.g., provider non-approval or logistical constraints such as patient moving out of town)
Key Trial Info
Start Date :
February 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04275830
Start Date
February 4 2020
End Date
February 4 2022
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HonorHealth
Scottsdale, Arizona, United States, 85258